Drug abuse treatment as an HIV prevention strategy: a review

Sorensen, James L.; Copeland, Amy L.

doi:10.1016/s0376-8716(99)00104-0

Cited by 279 publications

(205 citation statements)

References 51 publications

Supporting

Mentioning

190

Contrasting

Unclassified

Order By: Relevance

“…Moreover, severity of drug dependence, quality of life, and HIV risk taking behaviors have been shown to have an important impact on the success of treatment interventions for substance abuse patients and on the social adjustment of the patients and their family members (Sorensen and Copeland, 2000;Teichner et al, 2001;Hudson et al, 2002;Kampman et al, 2004). For researchers, our findings suggest that BZD use prior to admission should be considered as a covariate in analyses of treatment outcome in clinical trials.…”

Section: Discussionmentioning

confidence: 87%

“…These outcome measures were assessed with validated instruments (Weissman et al, 1978;Weissman et al, 1981;Goldman et al, 1992). They have been shown to be important indicators of treatment success (Sorensen and Copeland, 2000;Teichner et al, 2001;Hudson et al, 2002;Kampman et al, 2004). To have adequate statistical power, we combined data from two of our clinical trials evaluating the efficacy of CM for heroin/cocaine abuse Ghitza et al, 2007Ghitza et al, , 2008.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome

Ghitza

Epstein

Preston

2008

Drug and Alcohol Dependence

View full text Add to dashboard Cite

The relationship between pretreatment illicit benzodiazepine use (days of use in the last 30) assessed on the Addiction Severity Index (ASI) and treatment outcome was investigated by retrospective analysis of data from two controlled clinical trials in 361 methadone maintained cocaine/opiate users randomly assigned to 12-week voucher-or prize-based contingency management (CM) or control interventions. Based on screening ASI, participants were identified as nonusers (BZD-N; 0 days of use) or users (BZD-U; >0 days of use). Outcome measures were: urine drug screens (thrice weekly); quality of life and self-reported HIV-risk behaviors (every 2 weeks); and current DSM-IV diagnosis of cocaine and heroin dependence (study exit). In the CM group, BZD-U had significantly worse outcomes on in-treatment cocaine use, quality-of-life scores, needle-sharing behaviors, and current heroin dependence diagnoses at study exit compared to BZD-N. In the control group, BZD-U had significantly higher in-treatment cocaine use but did not differ from BZD-N on psychosocial measures. Thus, in a sample of non-dependent BZD users, self-reported illicit BZD use on the ASI, even at low levels, predicted worse outcome on cocaine use and blunted response to CM.

show abstract

Section: Discussionmentioning

confidence: 87%

Section: Introductionmentioning

confidence: 99%

Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome

Ghitza

Epstein

Preston

2008

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

“…Persons who use substances participate in behaviors that place them and others at substantial risk for these infections (Bachmann et al, 2000;Battjes et al, 1995;Belongia et al, 1997;Booth et al, 1993;Broers et al, 1998;Chiasson et al, 1991;Fortenberry et al, 1999;Francis, 2003;Garfein et al, 1998;Lorvich et al, 2001;Plitt et al, 2005;Poulin et al, 1999;Thomas et al, 1995;Zylberberg & Pol, 1996). Substance abuse treatment or various services provided in the mix of services in substance abuse treatments have been demonstrated to be important tools in developing effective responses to reduce the transmission of these infections (Brown, Chu, Nemoto, Ajuluchukwu, & Primm, 1989;Cooper, 1989;Hartel & Schoenbaum, 1998;Hubbard, Marsden, Cavanaugh, Rachal, & Ginsburg, 1988;Lally et al, 2002Lally et al, , 2005Metzger, Navaline, & Woody, 1998;Sorensen & Copeland, 2000). Determining that relevant services exist represents an important prerequisite to assessing effectiveness.…”

Section: Discussionmentioning

confidence: 99%

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

Brown¹,

Kritz²,

Goldsmith³

et al. 2006

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Illicit drug users sustain the epidemics of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hepatitis C (HCV), and sexually transmitted infections (STIs). Substance abuse treatment programs present a major intervention point in stemming these epidemics. As a part of the "Infections and Substance Abuse" study, established by the National Drug Abuse Treatment Clinical Trials Network, sponsored by National Institute on Drug Abuse, three surveys were developed; for treatment program administrators, for clinicians, and for state and District of Columbia health and substance abuse department administrators, capturing service availability, government mandates, funding, and other key elements related to the three infection groups. Treatment programs varied in corporate structure, source of revenue, patient census, and medical and non-medical staffing; medical services, counseling services, and staff education targeted HIV/ AIDS more often than HCV or STIs. The results from this study have the potential to generate hypotheses for further health services research to inform public policy.

show abstract

“…24 Effectiveness of opioid substitution treatment The best evidence of the effectiveness of drug dependence treatment in preventing HIV transmission among IDUs is for opioid substitution treatment programs using methadone and buprenorphine. [25][26][27] The evidence is much stronger for methadone than for buprenorphine treatment. 27,28 Methadone substantially reduces drug injecting and thereby the sharing of injecting equipment.…”

Section: Effectiveness Of Needle and Syringe Programsmentioning

confidence: 99%

The effectiveness of harm reduction in preventing HIV among injecting drug users

Wodak¹,

Maher²

2010

NSW Public Health Bull.

View full text Add to dashboard Cite

show abstract

Drug abuse treatment as an HIV prevention strategy: a review

Cited by 279 publications

References 51 publications

Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome

Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

The effectiveness of harm reduction in preventing HIV among injecting drug users

Contact Info

Product

Resources

About